To Evaluate the Safety, Tolerability and Pharmacokinetics of Oral NNZ-2591 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 29, 2020

Primary Completion Date

February 11, 2021

Study Completion Date

February 11, 2021

Conditions

Healthy Volunteers

Interventions

DRUG

NNZ-2591

Single dose of NNZ-2591

DRUG

Placebo

Comparator for double-blind MAD

Trial Locations (2)

Scientia Clinical Research, Sydney

Linear Clinical Research, The Queen Elizabeth II Medical Centre, Nedlands